Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Zebrafish ACOT7

Cat.No. : ACOT7-1336Z
Product Overview : Recombinant Zebrafish ACOT7 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Zebrafish
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 eu per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC.
Storage Buffer : PBS buffer
Gene Name : acot7 acyl-CoA thioesterase 7 [ Danio rerio (zebrafish) ]
Official Symbol : ACOT7
Gene ID : 447878
mRNA Refseq : NM_001004617
Protein Refseq : NP_001004617
UniProt ID : Q66I92

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (16)

Ask a question
Can ACOT7 protein be used as a diagnostic marker for diseases? 05/21/2021

There is currently limited evidence to suggest that ACOT7 could be used as a diagnostic marker for diseases. However, some studies have shown that higher levels of ACOT7 expression or activity are associated with certain diseases, such as breast cancer and non-alcoholic fatty liver disease. Further research is needed to determine the clinical utility of ACOT7 as a diagnostic marker.

Can ACOT7 protein be used as a biomarker for diseases? 02/28/2021

There is limited research on using ACOT7 as a biomarker for diseases, but some studies have suggested that it could be a potential diagnostic or prognostic marker for certain types of cancer. For example, higher levels of ACOT7 expression have been found in breast cancer samples compared to normal tissue, and this has been associated with poorer prognosis and survival rates.

How is ACOT7 protein being investigated for medical applications? 01/15/2021

Researchers are studying the effects of inhibiting or activating ACOT7 in animal models of disease to assess its potential as a therapeutic target. They are also investigating the use of ACOT7 expression levels as a biomarker for certain metabolic disorders. Some early studies suggest that inhibiting ACOT7 in the liver can reduce liver fat accumulation in animal models of fatty liver disease.

Are there any dietary or lifestyle factors that affect ACOT7 protein expression or function? 09/09/2019

There is limited research on the effects of diet and lifestyle factors on ACOT7 protein, but some studies have suggested that certain dietary components, such as omega-3 fatty acids, may affect its expression and activity. Additionally, exercise has been shown to increase the expression of ACOT7 in muscle tissue, suggesting that it may play a role in the metabolic benefits of exercise. However, more research is needed to fully understand the effects of diet and lifestyle on ACOT7 protein.

Can ACOT7 protein be used as a biomarker for diseases? 08/19/2019

There is limited research on using ACOT7 as a biomarker for diseases, but some studies have suggested that it could be a potential diagnostic or prognostic marker for certain types of cancer. For example, higher levels of ACOT7 expression have been found in breast cancer samples compared to normal tissue, and this has been associated with poorer prognosis and survival rates.

Are there any dietary or lifestyle factors that affect ACOT7 protein expression or function? 02/18/2019

There is limited research on the effects of diet and lifestyle factors on ACOT7 protein, but some studies have suggested that certain dietary components, such as omega-3 fatty acids, may affect its expression and activity. Additionally, exercise has been shown to increase the expression of ACOT7 in muscle tissue, suggesting that it may play a role in the metabolic benefits of exercise. However, more research is needed to fully understand the effects of diet and lifestyle on ACOT7 protein.

Are there any known genetic mutations that affect ACOT7 protein? 12/04/2018

Yes, there have been genetic variants identified in the ACOT7 gene that are associated with various diseases, including fatty liver disease, obesity, and type 2 diabetes. These variants affect the expression or function of ACOT7 protein, highlighting the importance of ACOT7 in regulating lipid metabolism and energy homeostasis.

Is ACOT7 protein involved in autophagy? 11/14/2018

Yes, there have been studies suggesting that ACOT7 plays a role in regulating autophagy, a cellular process involved in the degradation and recycling of cellular components. Specifically, ACOT7 has been shown to regulate the levels of acyl-CoA molecules, which can affect autophagic activity. This suggests that targeting ACOT7 could affect autophagy and potentially lead to therapeutic benefits in diseases where autophagy is dysregulated.

Can ACOT7 protein be used in basic research to study lipid metabolism? 04/01/2018

Yes, ACOT7 is a key regulator of lipid metabolism, and it could be used as a tool for studying various aspects of this process. For example, researchers could study how ACOT7 regulates fatty acid oxidation or lipid signaling pathways, or how it interacts with other proteins involved in lipid metabolism. Additionally, understanding the function of ACOT7 could provide insights into the development of new therapies for metabolic diseases.

What are some potential applications of ACOT7 protein in medicine? 09/04/2017

ACOT7 has been implicated in a range of metabolic processes, including lipid metabolism and insulin signaling. As such, it has the potential to be a target for the development of treatments for metabolic disorders such as obesity, type 2 diabetes, and fatty liver disease.

Is it possible to develop drugs that target ACOT7 protein? 07/08/2017

Yes, there are several potential ways to target ACOT7 with drugs. One approach could be to develop small molecules that selectively inhibit ACOT7 activity, which could be tested in preclinical models of metabolic diseases. Another approach could be to target ACOT7 expression using gene therapy or RNA interference techniques, although this would require further optimization and safety testing.

Is ACOT7 protein involved in autophagy? 04/23/2016

Yes, there have been studies suggesting that ACOT7 plays a role in regulating autophagy, a cellular process involved in the degradation and recycling of cellular components. Specifically, ACOT7 has been shown to regulate the levels of acyl-CoA molecules, which can affect autophagic activity. This suggests that targeting ACOT7 could affect autophagy and potentially lead to therapeutic benefits in diseases where autophagy is dysregulated.

Can ACOT7 protein be used as a therapeutic target for diseases? 02/03/2016

Yes, ACOT7 has been suggested as a potential therapeutic target for metabolic diseases, such as obesity, type 2 diabetes, and fatty liver disease. A study has shown that inhibiting ACOT7 activity in mice improved insulin sensitivity and decreased liver fat accumulation, indicating that targeting ACOT7 could have therapeutic benefits in these diseases.

Are there any natural compounds that can affect ACOT7 protein expression or function? 01/26/2016

Yes, some natural compounds have been shown to affect ACOT7 expression or activity. For example, omega-3 fatty acids have been shown to increase ACOT7 expression in muscle tissue, potentially contributing to the metabolic benefits of these compounds. Additionally, curcumin, a bioactive compound found in turmeric, has been shown to inhibit ACOT7 activity in vitro, indicating that it could be a potential therapeutic agent for metabolic diseases.

Are there any drugs that target ACOT7 protein? 10/30/2015

Currently, there are no drugs available that specifically target ACOT7 protein. However, several small molecule inhibitors of ACOT7 have been identified in early-stage research studies and are being tested for their potential as therapeutic agents.

What are some challenges to developing treatments based on ACOT7 protein? 01/24/2015

One challenge is that ACOT7 is just one of several acyl-CoA thioesterase enzymes in the body, each with varying tissue distribution and substrate specificity. Therefore, it can be difficult to ensure that activating or inhibiting ACOT7 will have the desired effects without impacting other metabolic processes in the body. Additionally, more research is needed to fully understand the potential role of ACOT7 in various metabolic disorders and to develop safe and effective drugs that target it.

Customer Reviews (0)

Write a review

Ask a Question for All ACOT7 Products

Required fields are marked with *

My Review for All ACOT7 Products

Required fields are marked with *

0

Inquiry Basket

cartIcon
logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends